The Perivascular Fat Attenuation Index: Bridging Inflammation and Cardiovascular Disease Risk
Journal of Clinical Medicine · 04.07.2025 · 14 (13) · 4753
DOI: 10.3390/jcm14134753 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.07.2025. Verfasst von Eliška Němečková und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was funded by the Ministry of Education, Youth and Sports of the Czech Republic, INTER-EXCELLENCE II, Ministry of Education, Youth and Sports of the Czech Republic.
Abstract (Originalsprache)
Cardiovascular disease remains the leading global cause of mortality, with inflammation now recognized as a central driver of atherosclerosis and other cardiometabolic conditions. Recent advances have repositioned perivascular adipose tissue from a passive structural element to an active endocrine and immunomodulatory organ, now a key focus in cardiovascular and metabolic research. Among the most promising tools for assessing perivascular adipose tissue inflammation is the fat attenuation index, a non-invasive imaging biomarker derived from coronary computed tomography angiography. This review explores the translational potential of the fat attenuation index for cardiovascular risk stratification and treatment monitoring in both coronary artery disease and systemic inflammatory or metabolic conditions (psoriasis, systemic lupus erythematosus, inflammatory bowel disease, obesity, type 2 diabetes, and non-obstructive coronary syndromes). We summarize evidence linking perivascular adipose tissue dysfunction to vascular inflammation and adverse cardiovascular outcomes. Clinical studies reviewing the fat attenuation index highlight its ability to detect subclinical inflammation and monitor treatment response. As research advances, standardization of measurement protocols and imaging thresholds will be essential for routine clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic.
ORCID-Profile: Eliška Němečková, Martin Malý
Förderung
- This work was funded by the Ministry of Education, Youth and Sports of the Czech Republic, INTER-EXCELLENCE II
- Ministry of Education, Youth and Sports of the Czech Republic
Zitieren
APA
Němečková, E., Krása, K., & Malý, M. (2025). The Perivascular Fat Attenuation Index: Bridging Inflammation and Cardiovascular Disease Risk. Journal of Clinical Medicine, 14(13), 4753. https://doi.org/10.3390/jcm14134753
Vancouver
Němečková E, Krása K, Malý M. The Perivascular Fat Attenuation Index: Bridging Inflammation and Cardiovascular Disease Risk. Journal of Clinical Medicine. 2025;14(13):4753. doi:10.3390/jcm14134753
BibTeX
@article{Nmekov2025,
author = {Němečková, Eliška and Krása, Kryštof and Malý, Martin},
title = {The Perivascular Fat Attenuation Index: Bridging Inflammation and Cardiovascular Disease Risk},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {13},
pages = {4753},
doi = {10.3390/jcm14134753}
}
EUVIMED